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Background: High serum total cholesterol levels represent a risk factor of ischemic 
stroke in Western countries. However, this association has not been thoroughly 
investigated in Asian populations where the incidence of stroke is high.  
Methods: Participants were 11,727 men and 21,742 women aged 40-69 years, all free 
of cardiovascular disease and cancer at baseline. During the median 12-year follow-up, 
we documented 612 ischemic stroke (293 lacunar infarction, 107 large-artery 
occlusive infarctions, and 168 embolic infarctions).  
Results: Excess risk of ischemic stroke was observed in men with serum total 
cholesterol levels of ≥6.21 mmol/L than those with the lowest category (<4.65 
mmol/L), but not in women. The multivariable hazard ratios (HRs) and 95% 
confidence interval (95%CI) were 1.63(1.14-2.35) for men and 1.03(0.69-1.55) for 
women. The corresponding HRs of large-artery occlusive infarction were 
2.86(1.31-6.27) for men and 0.75(0.28-2.01) for women. Serum total cholesterol levels 
were not associated with risk of lacunar or embolic infarction for either sex. 
Conclusions: High serum total cholesterol is a risk factor of ischemic stroke, 
specifically large-artery occlusive infarction for Japanese men. 
Key words: Cholesterol ■ Ischemic stroke ■ Epidemiology ■ Follow-up study 
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1. Introduction  
Associations of high serum total cholesterol levels with increased risk of ischemic 
stroke have been reported for Americans [1], Europeans [2], and Japanese-American 
men [3]. As for ischemic stroke subtypes, the positive association with total 
cholesterol levels was confined to atherothrombotic infarction according to another  
study of Americans men and women [4]. Only one study in Japan reported that serum 
total cholesterol levels was positively associated with increased age-adjusted risk of 
atherothrombotic infarction for Japanese women aged ≥40 years but not for men [5]. 
In that study, however, the multivariable-adjustment was not performed probably due 
to the limited number of cases [5]. No other studies of Asian populations found a 
positive association between high serum total cholesterol levels and risk of ischemic 
stroke [6-10]. 
The aim of the current study was to examine the relation between serum total 
cholesterol levels and risk of ischemic stroke subtypes in a large Japanese cohort. 
According to a national survey conducted in Japan, mean serum total cholesterol levels 
increased from 4.81mmol/L in 1980 to 5.17mmol/L in 2000 for men and from 4.94 to 
5.38mmol/L for women aged ≥30 years [11]. The levels in 2000 were not significantly 
different from those for US adults aged ≥20 years in 1999-2000 reported by the 
National Health and Nutrition Examination (NHANES) survey: 5.23mmol/L for men 
and 5.29mmol/L for women [12]. In addition, the prevalence of serum total cholesterol 
≥6.21mmol/L increased from 6% to 12% for men and from 9% to 17% for women 
from the 1980s to the 2000s in Japan [11]. 
It is therefore important to conduct a thorough investigation of the associations 
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between serum total cholesterol levels and risk of ischemic stroke in a large Japanese 
cohort. The Japan Public Health Center based prospective (JPHC) study, which is a 
community-based study of cardiovascular disease in one of the largest Asian cohorts.  
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2. Methods 
2.1. Surveyed populations 
The JPHC study consisted of cohort І, conducted in 1990 with a population aged 40-59 
and cohort ІІ, conducted in 1993-1994 with a population aged 40-69 at 11 public 
health center areas throughout Japan. A total of 113,461 subjects participated in the 
JPHC study (overall response rate: 81%) and the health checkup data were collected 
from 34% of the subjects [13]. Two public health center areas from Tokyo and Osaka 
were excluded from this study because stroke incidence data were not available. Data 
regarding lifestyle, serum total cholesterol and high-density lipoprotein (HDL) choles-
terol, blood pressure, height in stocking feet and weight in light clothing were obtaina-
ble for 34,780 subjects (12,195 men and 22,585 women). These subjects participated 
in the health checkup examinations during the same year as the baseline survey. We 
excluded the subjects who self-reported coronary heart disease, stroke or cancer at 
baseline. This left a total of 33,469 subjects (11,727 men and 21,742 women) who 
were used for the analyses. The study protocol was approved by the human ethics re-
view committees of the National Cancer Center and Osaka University Graduate 
School of Medicine. 
 
2.2 . Baseline Questionnaire and Health Check-up Examination 
A self-administered questionnaire was administered at baseline and covered med-
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ical history, smoking habit and alcohol consumption. The amount of ethanol per week 
was estimated based on the weekly frequency of drinking. Hypertension was defined 
as a systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg 
and/or antihypertensive medication use. Persons who smoked ≥1cigarette/day were 
defined as current smokers. Body mass index (BMI) was calculated as weight (kg) di-
vided by square of height (m2).  
Data for serum total cholesterol and HDL- cholesterol in non-fasting state were 
available. Serum total cholesterol was measured by using an enzymatic method at 23 
laboratories. According to the Osaka Medical Center for Health Science and Promo-
tion, a member of the US Cholesterol Reference Method Laboratory Network [14], the 
precision and accuracy of the cholesterol measurements at all laboratories were satis-
factory, with a mean coefficient of variation of 0.78% for precision and a mean per-
centage bias versus the target value of ±0.30%. Non HDL-cholesterol (mmol/L) was 
calculated by total cholesterol (mmol/L) minus HDL cholesterol (mmol/L). 
 
2.3. Confirmation of Stroke Incidence  
A total of 78 hospitals were registered in the sampling areas of the JPHC cohort. 
They were all major hospitals where acute stroke cases would be admitted. All medical 
records of strokes were reviewed by hospital physicians, public health center physi-
Page 7 
cians, or research physicians who were blinded to the baseline data, using standard 
format of registry. Stroke events were registered during the baseline survey and Janu-
ary 1, 2005. 
To complete the surveillance for fatal stroke, we also conducted a systematic 
search of death certificates. For all fatal strokes was determined based on the codes 
I60-I69 of the International Classification of Diseases, 10th Revision (ICD-10), and 
that had been listed on the death certificate but not registered. Medical records at the 
registered hospitals were reviewed by hospital workers, research physician, and epi-
demiologists.  
For non-fatal strokes, we asked by letter or telephone about the onset of stroke 
and for permission to review the medical records of those who had reported a history 
of non-fatal stroke on the 5th- and 10th-year follow-up questionnaire but had not been 
registered as stroke cases. Again, all these medical records were reviewed by hospital 
workers, research physicians, or epidemiologists. Stroke was confirmed based on 
medical records and meeting the criteria of the National Survey of Stroke [15], which 
requires a constellation of neurological deficits of sudden or rapid onset lasting at least 
24 hours or until death. Strokes were classified as ischemic stroke (lacunar, 
large-artery occlusive, embolic and unclassified infarctions) and hemorrhagic stroke 
(intracerebral or subarachnoid hemorrhage) and stroke of undetermined type, primarily 
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based on computed tomography (CT), magnetic resonance imaging (MRI) or autopsy 
findings [16]. Infarcts ≤1.5 cm in diameter at based ganglion and/or pons on brain im-
aging were classified as lacunar infarction, while infarcts >1.5 cm involing cortical ar-
eas to be of large-artery occlusive infarction. Definite of embolic infarction required 
the same criteria as ischemic infarction, plus either a source of possible cerebral embo-
li in a vessel or the presence of an embolus in the brain or medical record evidence of a 
possible source of embolus. A stroke case that was diagnosed clinically but showed no 
lesions on CT, MRI or autopsy was classified as stroke of undetermined type.  
 
2.4. Statistical Analyses 
Statistical analyses were based on incidence rates of stroke during the median 12 years 
of follow-up from 1990 in cohort І and from 1993-1994 in cohort ІІ to the end of 2004. 
For each person-years of follow-up were calculated from baseline survey until which-
ever stroke or coronary heart disease came first, death (6.1% of the participants), emi-
gration (4.2% of the participants) or January 1, 2005. The cut-off points of serum total 
cholesterol based on the combination of clinical criteria from the adult treatment panel 
III (4.14, 5.17 and 6.21mmol/L) [17] and the Japan Atherosclerotic Society Guideline 
(5.69 mmol/L) [18]. We added 4.65 mmol/L as an additional cut-off because there was 
a large number of participants with serum total cholesterol of 4.14-4.64 mmol/L. The 
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categorioes of serum total cholesterol <4.14 mmol/L and 4.14-4.64 mmol/L were 
combined because of the small number of incident cases in the category of serum total 
cholesterol <4.14 mmol/L. Consequently, the HRs and 95%CI of stroke and stroke 
subtypes were defined as the incidence of these outcomes for the categories of serum 
total cholesterol, 4.65-5.16 (180-199), 5.17-5.68 (200-219), 5.69-6.20 (220-239), and 
≥6.21mmol/L (240mg/dL), divided by that for the reference category of <4.65mmol/L 
(180mg/dL).  
The sex-specific age-adjusted differences in baseline risk characteristics among 
the categories of serum total cholesterol levels were deteremined with the analysis of 
covariance and chi-square test. Sex-specific HRs and 95%CI of stroke and its subtypes 
were calculated after adjusting for age and other potentially confounding factors by 
using the Cox proportional hazards model. We also analyzed the data with the 
time-dependent covariate Cox proportional hazards model using the additional data of 
lipid profiles for 13,243 persons (40% of the participans) who had undergone exami-
nation of blood lipids twice. 
Potentially confounding factors selected for adjustment were baseline values of 
age (year), BMI (quartiles), systolic blood pressure (mmHg), serum HDL-cholesterol 
levels (quartiles), smoking status (never, ex- and current smoking 1-19, 20-29, and ≥30 
cigarattes/day), alcohol consumption status (never, ex- and current drinking: ethanol 
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intake <150, 150-299, 300-449, ≥450g/week), diabetes (yes/no), medication use for 
hypertension (yes/no) and hyperlipedemia (yes/no), and study area (9 public health 
center areas).  
All p values for statistical tests were two-tailed and p value <0.05 was regarded as 
statistically significant. SAS (version 9.13) was used for all statistical analyses. 
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3. Results 
Table 1 shows the population characteristics at baseline examination for the five 
categories of serum total cholesterol levels. Compared to persons with serum total 
cholesterol levels <4.65 mmol/L, persons with levels of ≥6.21 mmol/L had higher 
mean values of BMI, systolic and diastolic blood pressure levels, HDL-cholesterol 
levels, and were more likely to be hypertensive, have diabetes mellitus and use 
medication for hyperlipidemia. These associations held true for both men and women, 
but the men with higher total cholesterol levels were younger and smoked less while 
such women were older. The subjects with cholesterol values were 3 to 4 years older 
than those without it for either sex (not shown in Table). However, there were no 
substantial differences in means of BMI or proportion of history of hypertension and 
diabetes at baseline except for the proportion of current smoking (men: 45% vs. 55%, 
women: 3% vs. 8%). 
During the median 12-year follow-up of 11,727 men and 21,742 women aged 
40-69 years, we documented 622 total strokes for men, composing of 207 hemorrhagic 
strokes, 354 ischemic strokes (156 lacunar infarctions, 66 large-artery occlusive and 
104 cardioembolic infarctions, as well as 28 unclassified ischemic strokes) and 61 
stroke of undermined type. The corresponding numbers for women were 563, 263 and 
258 (137, 41, 64, and 16) and 42.  
Age-adjusted risks of ischemic stroke and large-artery occlusive infarction were 
higher for men with serum total cholesterol levels of ≥6.21 mmol/L than those with 
serum levels <4.65 mmol/L but women did not show such associations (Tables 2 and 
3). After adjustment for other cardiovascular risk factors, these associations did not 
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change substantially. The multivariable HRs (95%CI) of ischemic stroke and 
large-artery occlusive infarction for serum total cholesterol levels of ≥6.21 mmol/L 
versus <4.65 mmol/L were 1.63(1.14-2.35) and 2.86(1.31-6.27) respectively for men, 
and 1.03(0.69-1.55) and 0.75(0.28-2.01) for women. The respective multivariable HRs 
(95%CI) for 1 mmol/L increment of total cholesterol levels were 1.14(1.02-1.28) and 
1.30(1.04-1.63) for men, and 1.05(0.92-1.21) and 0.88(0.62-1.24) for women. These 
associations did not change substantially when they were analyzed with the 
time-dependent covariate Cox proportional model. The resultant corresponding HRs 
(95%CI) were 1.84(1.33-2.54) and 2.44(1.05-5.70) for men, and 0.96(0.63-1.47) and 
0.87(0.35-2.21) for women. The respective multivariable HRs (95%CI) for 1 mmol/L 
increment of total cholesterol levels were 1.14(1.03-1.27) and 1.24(0.97-1.58) for men, 
and 1.04(0.90-1.19) and 1.06(0.76-1.47) for women. 
Non HDL-cholestrol levels were also associated with risk of ischemic stroke; the 
multivariable HRs (95%CI) of ischemic stroke for 1mmol/L increment of non 
HDL-cholesterol were 1.14(0.99-1.32) for men, 1.16(0.98-1.37) for women, and 
1.11(1.00-1.24) for men and women (not shown in Table). 
The association of high total cholesterol levels with risk of ischemic stroke tended 
to be stronger for men aged 40-59 years than for the older men, but an opposite trend 
was observed for women, the multivariable HR (95%CI) of ischemic stroke for 1 
mmol/L increment of total cholesterol levels was 1.22(1.05-1.41) for men aged 40-59 
years and 1.06(0.89-1.27) for those aged 60-69 years, p for interaction=0.10; and 
0.97(0.80-1.17) and 1.19(0.97-1.47), p for interaction=0.94 respectively for women 
(not shown in Table). 
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4. Discussion 
As a result of the median 12-year follow-up of middle-aged Japanese, we found 
that men with serum total cholesterol levels of ≥6.21 mmol/L had a 1.7-fold higher 
risk of ischemic stroke than those with serum total cholesterol <4.65 mmol/L. Our 
finding is consistent with the results of previous studies: the multivariable HR for 
serum total cholesterol <4.14 versus ≥6.21 mmol/L was 1.8 for American men [1], and 
that for serum total cholesterol <4.91 versus ≥6.21 mmol/L was 1.4 for 
Japanese-American men [3]. 
This report constitutes the first evidence of the excess risk of ischemic stroke for 
men with high serum total cholesterol levels in an Asian population. The appearance of 
this excess risk may be due to an increase in levels of serum total cholesterol among 
Japanese during the past several decades [11,19]. While some studies have reported 
that serum total cholesterol is more strongly associated with non-embolic than with 
other types of infarction [3,20], we found that the association of excess risk associated 
with high serum total cholesterol levels held true primarily for large-artery occlusive 
infarction among men with a HR (95%) of 1.30 (1.04-1.63) per 1mmol/L increment of 
serum cholesterol levels. In support of this finding, the ARIC study of 14,448 men and 
women aged 45-64 years reported that a 1 mmol/L increment in serum cholesterol 
levels was associated with a 1.13 (1.02-1.26) higher risk of large-artery occlusive 
infarction [4]. In addition, a pathologic study of Japanese men provided evidence that 
serum total cholesterol levels were higher among fatal cases of large-artery occlusive 
infarction [21]. High serum total cholesterol levels may thus play an important role in 
the development of atherosclerotic lesions of basal and large cerebral arteries. In the 
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present study, a 1 mmol/L increment of non HDL-cholesterol levels was associated 
with the higher risk of ischemic stroke with HR of 1.11(1.00-1.24) for men and women 
combined. This result was consistent with that of a mata-analysis of 68 prospective 
studies, showing the corresponding HR were 1.12 (1.04-1.20) [22]. 
On the other hand, we found the lack of association between total cholesterol 
levels and risk of ischemic stroke in women, although the sex interaction did not reach 
statictical significance (p for interaction = 0.14). Our finding may be due to the shorter 
incubation period for the exposure to higher cholesterol levels primarily after 
menopause compared with men [23] and the smaller number of incident ischemic 
stroke. The result of age-stratified analysis for women a positive association of 
borderline statistical significance between serum total cholesterol levels and risk of 
ischemic stroke among women aged 60-69, supports this interpretation.  
The strengths of our prospective cohort study are that it has a large population base 
with a low pecentage of losses to follow-up and uses serum total cholesterol 
measurements standardized by the US cholesterol reference method laboratory 
network [14]. These advantages have resulted in a more realistic estimation of the 
association between serum total cholesterol and stroke incidence. Moreover, more than 
98% of the stroke incidence was confirmed by findings of CT, MRI or autopsy. These 
study characteristics enabled us to conduct analyses for subtypes of ischemic stroke as 
well.  
As for a limitation, the data of serum total cholesterol at baseline was available for 
only 34% of the study analysis. However, there was no significant difference in 
baseline characteristics between persons who had the cholesterol data and those 
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without the data, except for age and smoking. Second, the data of serum total 
cholesterol at baseline was used for the analysis, so that there is a possibility of 
intra-individual variability of cholesterol levels, which have may have attenuated the 
actual associations. However, the associations of high serum total cholesterol levels 
with risk of ischemic stroke did not alter when the time-dependent covariate Cox 
proportional model was applied.  
In conclusion, our study established that high serum total cholesterol is associated 
with risk of ischemic stroke, specifically large-artery occlusive infarction, for Japanese 
men.  
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Table1. Age-adjusted mean values and prevalence of risk factors according to serum total cholesterol category 
 Serum total cholesterol categories 
Range, mmol/L (mg/dL) <4.65 (180) 
4.65-5.16 
(180-199) 
5.17-5.68 
(200-219) 
5.69-6.20 
(220-239) ≥6.21 (240) 
Men       
Number 4,166 2,899 2,205 1,405 1,052 
Age, year 54.5 54.5 54.7 53.9* 53.6† 
HDL-cholesterol, mmol/L 1.35 1.43‡ 1.45‡ 1.49‡ 1.50‡ 
Body mass index, kg/m2 23.0 23.6‡ 23.6‡ 24.0‡ 24.3‡ 
Systolic blood pressure, mmHg 131.4 132.9** 133.3‡ 135.0‡ 136.6‡ 
Diastolic blood pressure, mmHg 79.2 80.4‡ 81.1‡ 81.6‡ 82.7‡ 
Alcohol intake, g/week 294.7 299.9 293.9 283.1 318.6 
Current smokers,% 50.2 45.3‡ 43.8‡ 40.3‡ 36.6‡ 
Hypertension, % 36.8 42.2‡ 41.9** 46.1‡ 51.8‡ 
Diabetes mellitus, % 6.1 5.9 6.2 6.1 8.5* 
Hyperlipidemia medication use, % 0.6 1.1 1.2* 1.6† 3.4‡ 
Women      
Number  5,095 4,731 4,801 3,627 3,488 
Age, year 51.1 53.4‡ 54.3‡ 55.8‡ 56.2‡ 
HDL-cholesterol, mmol/L 1.39 1.48‡ 1.52‡ 1.53‡ 1.54‡ 
Body mass index, kg/m2 23.2 23.4† 23.7‡ 24.0‡ 24.3‡ 
Systolic blood pressure, mmHg 127.5 128.4* 130.4‡ 130.6‡ 132.1‡ 
Diastolic blood pressure, mmHg 75.4 76.3‡ 77.8‡ 78.0‡ 79.0‡ 
Alcohol intake, g/week 69.2 84.8 99.4† 98.3* 79.4 
Current smokers,% 3.5 3.3 3.5 2.9 3.3 
Hypertension, % 28.9 31.0* 34.8‡ 35.8‡ 38.9‡ 
Diabetes mellitus, % 2.5 2.4 2.8 3.0 3.3* 
Hyperlipidemia medication use, % 0.9 1.1 1.9† 2.8‡ 5.9‡ 
*p<0.05, †p<0.01,‡p<0.001, compared with serun cholesterol <180mg/dL category. 
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Table 2. Hazard ratios (HR) and 95% confidence intervals of stroke and stroke subtypes according to serum total cholesterol levels 
 Serum total cholesterol categories HR for 1mmol/L  
increment Range, mmol/L (mg/dL) <4.65 (180) 4.65-5.16 (180-199) 5.17-5.68 (200-219) 5.69-6.20 (220-239) ≥6.21 (240) 
Men        
Person years 51,854 36,139 27,573 17,619 13,028  
Total stroke 217 159 117 67 62  
Age- adjusted HR  1.00 1.05(0.86-1.29) 1.00(0.80-1.26) 0.93(0.71-1.23) 1.20(0.91-1.59) 1.03(0.95-1.12) 
Multivariable HR 1.00 1.09(0.88-1.34) 1.04(0.83-1.31) 0.99(0.75-1.31) 1.24(0.92-1.65) 1.07(0.98-1.17) 
Hemorrhagic stroke  65 59 45 21 17  
Age- adjusted HR  1.00 1.30(0.92-1.85) 1.29(0.89-1.89) 0.96(0.59-1.58) 1.07(0.63-1.83) 1.06(0.92-1.24) 
Multivariable HR 1.00 1.26(0.88-1.80) 1.29(0.88-1.89) 0.93(0.57-1.54) 0.99(0.57-1.71) 1.05(0.90-1.23) 
Ischemic stroke 121 89 61 41 42  
Age- adjusted HR  1.00 1.05(0.80-1.38) 0.94(0.69-1.27) 1.03(0.72-1.46) 1.47(1.04-2.09)* 1.09(0.97-1.22) 
Multivariable HR 1.00 1.13(0.86-1.49) 1.00(0.73-1.37) 1.16(0.81-1.67) 1.63(1.14-2.35)† 1.14(1.02-1.28)* 
Women        
Person years 66,400 60,666 61,276 45,711 43,939  
Total stroke 110 128 107 110 108  
Age- adjusted HR  1.00 1.09(0.84-1.41) 0.86(0.65-1.12) 1.08(0.72-1.40) 1.08(0.83-1.42) 1.04(0.95-1.15) 
Multivariable HR 1.00 1.05(0.81-1.36) 0.79(0.61-1.04) 0.99(0.76-1.30) 0.95(0.72-1.25) 1.00(0.91-1.10) 
Hemorrhagic stroke  58 62 52 46 45  
Age- adjusted HR  1.00 1.05(0.73-1.51) 0.84(0.58-1.23) 0.94(0.63-1.39) 0.94(0.64-1.40) 0.96(0.84-1.10) 
Multivariable HR 1.00 1.00(0.70-1.44) 0.79(0.54-1.15) 0.89(0.59-1.32) 0.86(0.57-1.29) 0.93(0.81-1.07) 
Ischemic stroke 45 56 49 55 53  
Age- adjusted HR  1.00 1.12(0.75-1.66) 0.91(0.61-1.36) 1.22(0.82-1.80) 1.21(0.81-1.80) 1.12(0.98-1.28) 
Multivariable HR 1.00 1.11(0.75-1.65) 0.85(0.56-1.28) 1.13(0.76-1.69) 1.03(0.69-1.55) 1.05(0.92-1.21) 
*p<0.05, †p<0.01, ‡p<0.001 compared with lowest serum total cholesterol category. 
Multivariable adjusted for age, BMI, systolic blood pressure, HDL-cholesterol, smoking status, alcohol consumption status, diabetes, medication use for hypertension and 
hyperlipidemia, and study area.  
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Table 3. Hazard ratios (HR) and 95% confidence intervals of ischemic stroke subtypes according to serum total cholesterol levels 
 Serum total cholesterol categories HR for 1 mmol/L  
increment Range, mmol/L (mg/dL) <4.65 (180) 4.65-5.16 (180-199) 5.17-5.68 (200-219) 5.69-6.20 (220-239) ≥6.21 (240) 
Men        
Person years 51,854 36,139 27,573 17,619 13,028  
Lacunar infaction  51 39 32 19 15  
Age- adjusted HR  1.00 1.09 (0.72-1.66) 1.16 (0.75-1.81) 1.13 (0.67-1.91) 1.25 (0.70-2.22) 1.07(0.90-1.28) 
Multivariable HR 1.00 1.20 (0.79-1.84) 1.29 (0.82-2.02) 1.35 (0.78-2.31) 1.48 (0.82-2.68) 1.16(0.97-1.38) 
Large-artery occlusive infaction  18 20 8 9 11  
Age- adjusted HR  1.00 1.59 (0.84-3.01) 0.82 (0.36-1.90) 1.52 (0.68-3.38) 2.60 (1.23-5.51)* 1.29(1.01-1.64)* 
Multivariable HR 1.00 1.72(0.90-3.28) 0.88 (0.38-2.04) 1.71 (0.76-3.88) 2.86 (1.31-6.27)† 1.30(1.04-1.63)* 
Embolic infarction 39 22 18 13 12  
Age- adjusted HR  1.00 0.81 (0.48-1.36) 0.85 (0.49-1.49) 1.02 (0.54-1.90) 1.32 (0.69-2.53) 1.05(0.85-1.31) 
Multivariable HR 1.00 0.82 (0.48-1.39) 0.85 (0.48-1.50) 1.04 (0.55-1.99) 1.26 (0.65-2.48) 1.06(0.85-1.32) 
Women       
Person years 66,400 60,666 61,276 45,711 43,939  
Lacunar infaction  20 30 28 25 34  
Age- adjusted HR  1.00 1.33 (0.75-2.34) 1.15 (0.65-2.04) 1.22 (0.68-2.20) 1.70 (0.98-2.97) 1.21(1.01-1.46)* 
Multivariable HR 1.00 1.34 (0.76-2.37) 1.11 (0.62-1.98) 1.17 (0.65-2.13) 1.55 (0.88-2.74) 1.17(0.97-1.40) 
Large-artery occlusive infaction  9 12 3 9 8  
Age- adjusted HR  1.00 1.22 (0.51-2.89) 0.28 (0.08-1.05) 1.03 (0.41-2.61) 0.94 (0.36-2.45) 0.95(0.67-1.35) 
Multivariable HR 1.00 1.26 (0.54-3.00) 0.27 (0.07-1.01) 0.93 (0.36-2.39) 0.75 (0.28-2.01) 0.88(0.62-1.24) 
Embolic infarction 14 14 17 10 9  
Age- adjusted HR  1.00 0.90 (0.43-1.89) 1.02 (0.50-2.07) 0.72 (0.32-1.62) 0.66 (0.29-1.54) 0.92(0.69-1.21) 
Multivariable HR 1.00 0.93 (0.44-1.96) 0.99 (0.48-2.02) 0.68 (0.30-1.56) 0.57 (0.24-1.35) 0.87(0.65-1.16) 
*p<0.05, †p<0.01, ‡p<0.001 compared with lowest serum total cholesterol category.  
Multivariable adjustment variables were the same shown in Table 2. 
